Rosacea drug pipeline: are you updated?

Therapies in the investigational drug pipeline are joining existing treatment options for redness associated with rosacea, according to two clinicians.
» Full article

Pipeline offers promise for psoriasis therapies

Soon, dermatologists can expect to see their toolbox of highly effective systemic therapeutic options enriched by several new agents with novel mechanisms of action, according to presentations at the recent 2014 MauiDerm meeting. » Full article

Current and emerging therapies for psoriatic arthritis
Symptoms of psoriatic arthritis include inflammation in the joints and excessive production of skin cells. Learn about treatment options to help reduce these symptoms in your patients. View our psoriatic arthritis topic-based resource center and Learn More.

PODCAST: Advances in psoriasis treatment

The past few years have been an exciting time for those who treat psoriasis and for many patients with severe disease because of excellent new therapies for this often intractable problem. Norman Levine, M.D., spoke with Alan Menter, M.D., Baylor University Medical Center, Dallas, about recent developments in the treatment of psoriasis.
» Full article

Onychomycosis armamentarium set to expand with new options

Oral terbinafine has been the gold standard for treatment of onychomycosis for more than 20 years, but development of new therapeutic options has been the focus of some significant research activity.
» Full article

Filler lift a result of more than G prime

A new study shows for the first time in vivo that the concept of G prime alone fails to explain fully the lifting capacity of dermal fillers.» Full article

Downloads

You are subscribed to the Dermatology Times Issue Alert.

• ‘Chaos’ algorithm simplifies biopsy decision

• Establish brand to boost aesthetic practice progress

• Chemists try to mimic natural moisturizing factor

• Reconstitution is key to optimizing neurotoxin results